$ATRA News Article - Atara Biotherapeutics To Present Clinical Data in Epstein-Barr Virus-Driven (EBV+) Acquired & Primary Immunodeficiency Lymphoproliferative Diseases (AID-LPD and PID-LPD) from Tab-Cel Expanded Access Program in e-Poster at ESMO 2020 Virtual Congress
https://marketwirenews.com/news-releases/atar...28978.html